소 태아 혈청(FBS) 시장 : 시장 규모, 점유율, 동향 분석(용도별, 최종 용도별, 지역별), 부문별 예측(2026-2033년)

Fetal Bovine Serum Market Summary

The global fetal bovine serum market size was estimated at USD 2.35 billion in 2025 and is projected to reach USD 6.91 billion by 2033, growing at a CAGR of 14.51% from 2026 to 2033. Factors such as the biopharmaceutical industry's expansion in developing countries and established markets are expected to fuel the demand for fetal bovine serum (FBS) in the forecast period.

Expanding Biopharmaceutical & Biotechnology Industry

The growth of the global biopharmaceutical and biotechnology industry is a significant driver of demand in the FBS industry. FBS remains the gold standard supplement for cell culture media, providing vital nutrients, hormones, and growth factors supporting mammalian cells' survival and proliferation. Its applications span developing and producing biologics, vaccines, monoclonal antibodies, and recombinant proteins, therapeutic categories witnessing rapid adoption due to the rising burden of chronic diseases such as cancer, autoimmune disorders, and infectious diseases. As the biologics pipeline expands, the need for high-quality and consistent cell culture supplements is fueling steady consumption of FBS across research and commercial manufacturing settings.

Moreover, the increasing focus on advanced therapies such as cell therapy, gene therapy, and regenerative medicine has further heightened the importance of FBS in R&D and clinical-scale production. The surge in outsourcing to contract research and manufacturing organizations (CROs/CMOs) has also reinforced demand, as these entities rely on reliable and standardized inputs to support large-scale biologics production. These factors underscore how the expanding biopharmaceutical and biotechnology ecosystem acts as a central market driver for FBS, ensuring its sustained relevance despite the emergence of serum-free alternatives.

Global Fetal Bovine Serum Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global fetal bovine serum market report based on application, end use, and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Drug Discovery
• In-vitro Fertilization
• Vaccine Production
• Cell-based Research
• Diagnostics
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CRO)
• Academic & Research Organizations
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model
  • 1.4.1. Market Study, By Company Market Share
  • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, & Trends

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Expanding biopharmaceutical & biotechnology industry
    • 3.3.1.2. Rising cell-based research
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Presence of Alternatives
• 3.4. Industry Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. Macroeconomic Analysis

Chapter 4. Fetal Bovine Serum Market: Application Analysis

• 4.1. Application Segment Dashboard
• 4.2. Fetal Bovine Serum Market: Application Market Share Analysis
• 4.3. Fetal Bovine Serum Market Estimates & Forecast, By Application (USD Million)
• 4.4. Drug Discovery
  • 4.4.1. Global Drug Discovery Market, 2021 - 2033 (USD Million)
• 4.5. In-vitro Fertilization
  • 4.5.1. Global In-vitro Fertilization Process Market, 2021 - 2033 (USD Million)
• 4.6. Vaccine Production
  • 4.6.1. Global Vaccine Production Market, 2021 - 2033 (USD Million)
• 4.7. Cell-based Research
  • 4.7.1. Global Cell-based Research Market, 2021 - 2033 (USD Million)
• 4.8. Diagnostics
  • 4.8.1. Global Diagnostics Market, 2021 - 2033 (USD Million)
• 4.9. Others
  • 4.9.1. Global Others Market, 2021 - 2033 (USD Million)

Chapter 5. Fetal Bovine Serum Market: End Use Business Analysis

• 5.1. End Use Segment Dashboard
• 5.2. Fetal Bovine Serum Market: End Use Market Share Analysis
• 5.3. Fetal Bovine Serum Market Estimates & Forecast, By End Use (USD Million)
• 5.4. Pharmaceutical & Biotechnology Companies
  • 5.4.1. Global Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
• 5.5. Contract Research Organizations (CRO)
  • 5.5.1. Global Contract Research Organizations (CRO) Market, 2021 - 2033 (USD Million)
• 5.6. Academic and Research Organizations
  • 5.6.1. Global Academic and Research Organizations Market, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Global Others Market, 2021 - 2033 (USD Million)

Chapter 6. Fetal Bovine Serum Market: Regional Business Analysis

• 6.1. Fetal Bovine Serum Market Share By Region, 2025 & 2033
• 6.2. North America
  • 6.2.1. North America Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. Key Country Dynamics
    • 6.2.2.2. Competitive Scenario
    • 6.2.2.3. Regulatory Framework
    • 6.2.2.4. U.S. Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Competitive Scenario
    • 6.2.3.3. Regulatory Framework
    • 6.2.3.4. Canada Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Key Country Dynamics
    • 6.2.4.2. Competitive Scenario
    • 6.2.4.3. Regulatory Framework
    • 6.2.4.4. Mexico Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. UK Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Germany Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Regulatory Framework
    • 6.3.4.4. France Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. Competitive Scenario
    • 6.3.5.3. Regulatory Framework
    • 6.3.5.4. Italy Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Competitive Scenario
    • 6.3.6.3. Regulatory Framework
    • 6.3.6.4. Spain Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Competitive Scenario
    • 6.3.7.3. Regulatory Framework
    • 6.3.7.4. Denmark Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Key Country Dynamics
    • 6.3.8.2. Competitive Scenario
    • 6.3.8.3. Regulatory Framework
    • 6.3.8.4. Sweden Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Key Country Dynamics
    • 6.3.9.2. Competitive Scenario
    • 6.3.9.3. Regulatory Framework
    • 6.3.9.4. Norway Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. Japan Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. China Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. India Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. Australia Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.4.6. South Korea
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. South Korea Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.4.7. Thailand
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. Thailand Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Brazil Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Argentina Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
• 6.6. MEA
  • 6.6.1. MEA Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. South Africa Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Saudi Arabia Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. UAE Fetal Bovine Serum Market, 2021 - 2033 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Kuwait Fetal Bovine Serum Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Company Position Analysis, 2025
• 7.3. Strategy Mapping
• 7.4. Company Profiles/Listing
  • 7.4.1. Thermo Fisher Scientific Inc.
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Sartorius AG
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Danaher Corporation
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Merck KGaA
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. HiMedia Laboratories
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Bio-Techne
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. PAN-Biotech
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. Atlas Biologicals, Inc.
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Rocky Mountain Biologicals
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Biowest
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives